Thus, our study revealed the CRNDE/hnRNPA2B1/KARS axis played a critical driving role in CRC malignant progression, reserving a promising prognostic biomarker and potential therapeutic target for CRC. Here, HNRNPA2B1 is linked to colorectal carcinoma.